English
简体中文
Total: £ 56.28
Published Date: 2026-03-24 | Pages: 90 | Tables: 94 | Pharma & Healthcare
The global Live Attenuated Rotavirus Vaccine market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Live Attenuated Rotavirus Vaccine competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Rotavirus spreads easily among infants and young children. The virus can cause severe watery diarrhea, vomiting, fever, and abdominal pain. Children who get rotavirus disease can become dehydrated and may need to be hospitalized. Live attenuated rotavirus vaccine is a vaccine created by reducing the virulence of a pathogen, but still keeping it viable.
The North American market for Live Attenuated Rotavirus Vaccine is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Live Attenuated Rotavirus Vaccine is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Live Attenuated Rotavirus Vaccine include Merck Sharp & Dohme, GSK, Bharat Biotech, Lanzhou Biological Products Research Institute, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Live Attenuated Rotavirus Vaccine market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Live Attenuated Rotavirus Vaccine. The Live Attenuated Rotavirus Vaccine market size, estimates, and forecasts are provided in terms of sales volume (K Dose) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Live Attenuated Rotavirus Vaccine market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Live Attenuated Rotavirus Vaccine manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Merck Sharp & Dohme
GSK
Bharat Biotech
Lanzhou Biological Products Research Institute
Segment by Type
Monovalent Vaccines
Combination Vaccines
by Application
Hospitals and Clinics
Vaccination Sites
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Live Attenuated Rotavirus Vaccine manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Live Attenuated Rotavirus Vaccine sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Live Attenuated Rotavirus Vaccine Market Overview
1.1 Product Definition
1.2 Live Attenuated Rotavirus Vaccine by Type
1.2.1 Global Live Attenuated Rotavirus Vaccine Market Value by Type: 2025 vs 2032
1.2.2 Monovalent Vaccines
1.2.3 Combination Vaccines
1.3 Live Attenuated Rotavirus Vaccine by Application
1.3.1 Global Live Attenuated Rotavirus Vaccine Market Value by Application: 2025 vs 2032
1.3.2 Hospitals and Clinics
1.3.3 Vaccination Sites
1.4 Global Live Attenuated Rotavirus Vaccine Market Size Estimates and Forecasts
1.4.1 Global Live Attenuated Rotavirus Vaccine Revenue 2021–2032
1.4.2 Global Live Attenuated Rotavirus Vaccine Sales 2021–2032
1.4.3 Global Live Attenuated Rotavirus Vaccine Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Live Attenuated Rotavirus Vaccine Market Competition by Manufacturers
2.1 Global Live Attenuated Rotavirus Vaccine Sales Market Share by Manufacturers (2021–2026)
2.2 Global Live Attenuated Rotavirus Vaccine Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Live Attenuated Rotavirus Vaccine Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Live Attenuated Rotavirus Vaccine, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Live Attenuated Rotavirus Vaccine, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Live Attenuated Rotavirus Vaccine, Product Types and Applications
2.7 Global Key Manufacturers of Live Attenuated Rotavirus Vaccine, Date of Entry into the Industry
2.8 Global Live Attenuated Rotavirus Vaccine Market Competitive Situation and Trends
2.8.1 Global Live Attenuated Rotavirus Vaccine Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Live Attenuated Rotavirus Vaccine Players Market Share by Revenue
2.8.3 Global Live Attenuated Rotavirus Vaccine Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Live Attenuated Rotavirus Vaccine Market Scenario by Region
3.1 Global Live Attenuated Rotavirus Vaccine Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Live Attenuated Rotavirus Vaccine Sales by Region: 2021–2032
3.2.1 Global Live Attenuated Rotavirus Vaccine Sales by Region: 2021–2026
3.2.2 Global Live Attenuated Rotavirus Vaccine Sales by Region: 2027–2032
3.3 Global Live Attenuated Rotavirus Vaccine Revenue by Region: 2021–2032
3.3.1 Global Live Attenuated Rotavirus Vaccine Revenue by Region: 2021–2026
3.3.2 Global Live Attenuated Rotavirus Vaccine Revenue by Region: 2027–2032
3.4 North America Live Attenuated Rotavirus Vaccine Market Facts & Figures by Country
3.4.1 North America Live Attenuated Rotavirus Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Live Attenuated Rotavirus Vaccine Sales by Country (2021–2032)
3.4.3 North America Live Attenuated Rotavirus Vaccine Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Live Attenuated Rotavirus Vaccine Market Facts & Figures by Country
3.5.1 Europe Live Attenuated Rotavirus Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Live Attenuated Rotavirus Vaccine Sales by Country (2021–2032)
3.5.3 Europe Live Attenuated Rotavirus Vaccine Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Live Attenuated Rotavirus Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Live Attenuated Rotavirus Vaccine Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Live Attenuated Rotavirus Vaccine Sales by Region (2021–2032)
3.6.3 Asia Pacific Live Attenuated Rotavirus Vaccine Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Live Attenuated Rotavirus Vaccine Market Facts & Figures by Country
3.7.1 Latin America Live Attenuated Rotavirus Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Live Attenuated Rotavirus Vaccine Sales by Country (2021–2032)
3.7.3 Latin America Live Attenuated Rotavirus Vaccine Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Live Attenuated Rotavirus Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Live Attenuated Rotavirus Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Live Attenuated Rotavirus Vaccine Sales by Country (2021–2032)
3.8.3 Middle East and Africa Live Attenuated Rotavirus Vaccine Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Live Attenuated Rotavirus Vaccine Sales by Type (2021–2032)
4.1.1 Global Live Attenuated Rotavirus Vaccine Sales by Type (2021–2026)
4.1.2 Global Live Attenuated Rotavirus Vaccine Sales by Type (2027–2032)
4.1.3 Global Live Attenuated Rotavirus Vaccine Sales Market Share by Type (2021–2032)
4.2 Global Live Attenuated Rotavirus Vaccine Revenue by Type (2021–2032)
4.2.1 Global Live Attenuated Rotavirus Vaccine Revenue by Type (2021–2026)
4.2.2 Global Live Attenuated Rotavirus Vaccine Revenue by Type (2027–2032)
4.2.3 Global Live Attenuated Rotavirus Vaccine Revenue Market Share by Type (2021–2032)
4.3 Global Live Attenuated Rotavirus Vaccine Price by Type (2021–2032)
5 Segment by Application
5.1 Global Live Attenuated Rotavirus Vaccine Sales by Application (2021–2032)
5.1.1 Global Live Attenuated Rotavirus Vaccine Sales by Application (2021–2026)
5.1.2 Global Live Attenuated Rotavirus Vaccine Sales by Application (2027–2032)
5.1.3 Global Live Attenuated Rotavirus Vaccine Sales Market Share by Application (2021–2032)
5.2 Global Live Attenuated Rotavirus Vaccine Revenue by Application (2021–2032)
5.2.1 Global Live Attenuated Rotavirus Vaccine Revenue by Application (2021–2026)
5.2.2 Global Live Attenuated Rotavirus Vaccine Revenue by Application (2027–2032)
5.2.3 Global Live Attenuated Rotavirus Vaccine Revenue Market Share by Application (2021–2032)
5.3 Global Live Attenuated Rotavirus Vaccine Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Merck Sharp & Dohme
6.1.1 Merck Sharp & Dohme Company Information
6.1.2 Merck Sharp & Dohme Description and Business Overview
6.1.3 Merck Sharp & Dohme Live Attenuated Rotavirus Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Merck Sharp & Dohme Live Attenuated Rotavirus Vaccine Product Portfolio
6.1.5 Merck Sharp & Dohme Recent Developments/Updates
6.2 GSK
6.2.1 GSK Company Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Live Attenuated Rotavirus Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 GSK Live Attenuated Rotavirus Vaccine Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Bharat Biotech
6.3.1 Bharat Biotech Company Information
6.3.2 Bharat Biotech Description and Business Overview
6.3.3 Bharat Biotech Live Attenuated Rotavirus Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Bharat Biotech Live Attenuated Rotavirus Vaccine Product Portfolio
6.3.5 Bharat Biotech Recent Developments/Updates
6.4 Lanzhou Biological Products Research Institute
6.4.1 Lanzhou Biological Products Research Institute Company Information
6.4.2 Lanzhou Biological Products Research Institute Description and Business Overview
6.4.3 Lanzhou Biological Products Research Institute Live Attenuated Rotavirus Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Lanzhou Biological Products Research Institute Live Attenuated Rotavirus Vaccine Product Portfolio
6.4.5 Lanzhou Biological Products Research Institute Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Live Attenuated Rotavirus Vaccine Industry Chain Analysis
7.2 Live Attenuated Rotavirus Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Live Attenuated Rotavirus Vaccine Production Mode & Process Analysis
7.4 Live Attenuated Rotavirus Vaccine Sales and Marketing
7.4.1 Live Attenuated Rotavirus Vaccine Sales Channels
7.4.2 Live Attenuated Rotavirus Vaccine Distributors
7.5 Live Attenuated Rotavirus Vaccine Customer Analysis
8 Live Attenuated Rotavirus Vaccine Market Dynamics
8.1 Live Attenuated Rotavirus Vaccine Industry Trends
8.2 Live Attenuated Rotavirus Vaccine Market Drivers
8.3 Live Attenuated Rotavirus Vaccine Market Challenges
8.4 Live Attenuated Rotavirus Vaccine Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Live Attenuated Rotavirus Vaccine Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Live Attenuated Rotavirus Vaccine Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Live Attenuated Rotavirus Vaccine Market Competitive Situation by Manufacturers in 2025
Table 4. Global Live Attenuated Rotavirus Vaccine Sales (K Dose) of Key Manufacturers (2021–2026)
Table 5. Global Live Attenuated Rotavirus Vaccine Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Live Attenuated Rotavirus Vaccine Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Live Attenuated Rotavirus Vaccine Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Live Attenuated Rotavirus Vaccine Average Price (US$/Dose) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Live Attenuated Rotavirus Vaccine, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Live Attenuated Rotavirus Vaccine, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Live Attenuated Rotavirus Vaccine, Product Types and Applications
Table 12. Global Key Manufacturers of Live Attenuated Rotavirus Vaccine, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Live Attenuated Rotavirus Vaccine Companies by Tier (Tier 1, Tier 2, Tier 3), based on Live Attenuated Rotavirus Vaccine Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Live Attenuated Rotavirus Vaccine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Live Attenuated Rotavirus Vaccine Sales by Region (K Dose), 2021–2026
Table 18. Global Live Attenuated Rotavirus Vaccine Sales Market Share by Region (2021–2026)
Table 19. Global Live Attenuated Rotavirus Vaccine Sales by Region (K Dose), 2027–2032
Table 20. Global Live Attenuated Rotavirus Vaccine Sales Market Share by Region (2027–2032)
Table 21. Global Live Attenuated Rotavirus Vaccine Revenue by Region (US$ Million), 2021–2026
Table 22. Global Live Attenuated Rotavirus Vaccine Revenue Market Share by Region (2021–2026)
Table 23. Global Live Attenuated Rotavirus Vaccine Revenue by Region (US$ Million), 2027–2032
Table 24. Global Live Attenuated Rotavirus Vaccine Revenue Market Share by Region (2027–2032)
Table 25. North America Live Attenuated Rotavirus Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Live Attenuated Rotavirus Vaccine Sales by Country (K Dose), 2021–2026
Table 27. North America Live Attenuated Rotavirus Vaccine Sales by Country (K Dose), 2027–2032
Table 28. North America Live Attenuated Rotavirus Vaccine Revenue by Country (US$ Million), 2021–2026
Table 29. North America Live Attenuated Rotavirus Vaccine Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Live Attenuated Rotavirus Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Live Attenuated Rotavirus Vaccine Sales by Country (K Dose), 2021–2026
Table 32. Europe Live Attenuated Rotavirus Vaccine Sales by Country (K Dose), 2027–2032
Table 33. Europe Live Attenuated Rotavirus Vaccine Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Live Attenuated Rotavirus Vaccine Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Live Attenuated Rotavirus Vaccine Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Live Attenuated Rotavirus Vaccine Sales by Region (K Dose), 2021–2026
Table 37. Asia Pacific Live Attenuated Rotavirus Vaccine Sales by Region (K Dose), 2027–2032
Table 38. Asia Pacific Live Attenuated Rotavirus Vaccine Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Live Attenuated Rotavirus Vaccine Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Live Attenuated Rotavirus Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Live Attenuated Rotavirus Vaccine Sales by Country (K Dose), 2021–2026
Table 42. Latin America Live Attenuated Rotavirus Vaccine Sales by Country (K Dose), 2027–2032
Table 43. Latin America Live Attenuated Rotavirus Vaccine Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Live Attenuated Rotavirus Vaccine Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Live Attenuated Rotavirus Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Live Attenuated Rotavirus Vaccine Sales by Country (K Dose), 2021–2026
Table 47. Middle East and Africa Live Attenuated Rotavirus Vaccine Sales by Country (K Dose), 2027–2032
Table 48. Middle East and Africa Live Attenuated Rotavirus Vaccine Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Live Attenuated Rotavirus Vaccine Revenue by Country (US$ Million), 2027–2032
Table 50. Global Live Attenuated Rotavirus Vaccine Sales (K Dose) by Type (2021–2026)
Table 51. Global Live Attenuated Rotavirus Vaccine Sales (K Dose) by Type (2027–2032)
Table 52. Global Live Attenuated Rotavirus Vaccine Sales Market Share by Type (2021–2026)
Table 53. Global Live Attenuated Rotavirus Vaccine Sales Market Share by Type (2027–2032)
Table 54. Global Live Attenuated Rotavirus Vaccine Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Live Attenuated Rotavirus Vaccine Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Live Attenuated Rotavirus Vaccine Revenue Market Share by Type (2021–2026)
Table 57. Global Live Attenuated Rotavirus Vaccine Revenue Market Share by Type (2027–2032)
Table 58. Global Live Attenuated Rotavirus Vaccine Price (US$/Dose) by Type (2021–2026)
Table 59. Global Live Attenuated Rotavirus Vaccine Price (US$/Dose) by Type (2027–2032)
Table 60. Global Live Attenuated Rotavirus Vaccine Sales (K Dose) by Application (2021–2026)
Table 61. Global Live Attenuated Rotavirus Vaccine Sales (K Dose) by Application (2027–2032)
Table 62. Global Live Attenuated Rotavirus Vaccine Sales Market Share by Application (2021–2026)
Table 63. Global Live Attenuated Rotavirus Vaccine Sales Market Share by Application (2027–2032)
Table 64. Global Live Attenuated Rotavirus Vaccine Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Live Attenuated Rotavirus Vaccine Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Live Attenuated Rotavirus Vaccine Revenue Market Share by Application (2021–2026)
Table 67. Global Live Attenuated Rotavirus Vaccine Revenue Market Share by Application (2027–2032)
Table 68. Global Live Attenuated Rotavirus Vaccine Price (US$/Dose) by Application (2021–2026)
Table 69. Global Live Attenuated Rotavirus Vaccine Price (US$/Dose) by Application (2027–2032)
Table 70. Merck Sharp & Dohme Company Information
Table 71. Merck Sharp & Dohme Description and Business Overview
Table 72. Merck Sharp & Dohme Live Attenuated Rotavirus Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 73. Merck Sharp & Dohme Live Attenuated Rotavirus Vaccine Product
Table 74. Merck Sharp & Dohme Recent Developments/Updates
Table 75. GSK Company Information
Table 76. GSK Description and Business Overview
Table 77. GSK Live Attenuated Rotavirus Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 78. GSK Live Attenuated Rotavirus Vaccine Product
Table 79. GSK Recent Developments/Updates
Table 80. Bharat Biotech Company Information
Table 81. Bharat Biotech Description and Business Overview
Table 82. Bharat Biotech Live Attenuated Rotavirus Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 83. Bharat Biotech Live Attenuated Rotavirus Vaccine Product
Table 84. Bharat Biotech Recent Developments/Updates
Table 85. Lanzhou Biological Products Research Institute Company Information
Table 86. Lanzhou Biological Products Research Institute Description and Business Overview
Table 87. Lanzhou Biological Products Research Institute Live Attenuated Rotavirus Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 88. Lanzhou Biological Products Research Institute Live Attenuated Rotavirus Vaccine Product
Table 89. Lanzhou Biological Products Research Institute Recent Developments/Updates
Table 90. Key Raw Materials Lists
Table 91. Raw Materials Key Suppliers Lists
Table 92. Live Attenuated Rotavirus Vaccine Distributors List
Table 93. Live Attenuated Rotavirus Vaccine Customers List
Table 94. Live Attenuated Rotavirus Vaccine Market Trends
Table 95. Live Attenuated Rotavirus Vaccine Market Drivers
Table 96. Live Attenuated Rotavirus Vaccine Market Challenges
Table 97. Live Attenuated Rotavirus Vaccine Market Restraints
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
Table 101. Authors List of This Report
List of Figures
Figure 1. Product Picture of Live Attenuated Rotavirus Vaccine
Figure 2. Global Live Attenuated Rotavirus Vaccine Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Live Attenuated Rotavirus Vaccine Market Share by Type: 2025 & 2032
Figure 4. Monovalent Vaccines Product Picture
Figure 5. Combination Vaccines Product Picture
Figure 6. Global Live Attenuated Rotavirus Vaccine Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Live Attenuated Rotavirus Vaccine Market Share by Application: 2025 & 2032
Figure 8. Hospitals and Clinics
Figure 9. Vaccination Sites
Figure 10. Global Live Attenuated Rotavirus Vaccine Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 11. Global Live Attenuated Rotavirus Vaccine Market Size (US$ Million), 2021–2032
Figure 12. Global Live Attenuated Rotavirus Vaccine Sales (K Dose), 2021–2032
Figure 13. Global Live Attenuated Rotavirus Vaccine Average Price (US$/Dose), 2021–2032
Figure 14. Live Attenuated Rotavirus Vaccine Report Years Considered
Figure 15. Live Attenuated Rotavirus Vaccine Sales Share by Manufacturers in 2025
Figure 16. Global Live Attenuated Rotavirus Vaccine Revenue Share by Manufacturers in 2025
Figure 17. Top 5 and Top 10 Global Live Attenuated Rotavirus Vaccine Players: Market Share by Revenue in Live Attenuated Rotavirus Vaccine in 2025
Figure 18. Live Attenuated Rotavirus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 19. Global Live Attenuated Rotavirus Vaccine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 20. North America Live Attenuated Rotavirus Vaccine Sales Market Share by Country (2021–2032)
Figure 21. North America Live Attenuated Rotavirus Vaccine Revenue Market Share by Country (2021–2032)
Figure 22. United States Live Attenuated Rotavirus Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 23. Canada Live Attenuated Rotavirus Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Europe Live Attenuated Rotavirus Vaccine Sales Market Share by Country (2021–2032)
Figure 25. Europe Live Attenuated Rotavirus Vaccine Revenue Market Share by Country (2021–2032)
Figure 26. Germany Live Attenuated Rotavirus Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. France Live Attenuated Rotavirus Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. U.K. Live Attenuated Rotavirus Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. Italy Live Attenuated Rotavirus Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Russia Live Attenuated Rotavirus Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Asia Pacific Live Attenuated Rotavirus Vaccine Sales Market Share by Region (2021–2032)
Figure 32. Asia Pacific Live Attenuated Rotavirus Vaccine Revenue Market Share by Region (2021–2032)
Figure 33. China Live Attenuated Rotavirus Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Japan Live Attenuated Rotavirus Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. South Korea Live Attenuated Rotavirus Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. India Live Attenuated Rotavirus Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Australia Live Attenuated Rotavirus Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. China Taiwan Live Attenuated Rotavirus Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Southeast Asia Live Attenuated Rotavirus Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Latin America Live Attenuated Rotavirus Vaccine Sales Market Share by Country (2021–2032)
Figure 41. Latin America Live Attenuated Rotavirus Vaccine Revenue Market Share by Country (2021–2032)
Figure 42. Mexico Live Attenuated Rotavirus Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Brazil Live Attenuated Rotavirus Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Argentina Live Attenuated Rotavirus Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Colombia Live Attenuated Rotavirus Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Middle East and Africa Live Attenuated Rotavirus Vaccine Sales Market Share by Country (2021–2032)
Figure 47. Middle East and Africa Live Attenuated Rotavirus Vaccine Revenue Market Share by Country (2021–2032)
Figure 48. Turkey Live Attenuated Rotavirus Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Saudi Arabia Live Attenuated Rotavirus Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. UAE Live Attenuated Rotavirus Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Global Sales Market Share of Live Attenuated Rotavirus Vaccine by Type (2021–2032)
Figure 52. Global Revenue Market Share of Live Attenuated Rotavirus Vaccine by Type (2021–2032)
Figure 53. Global Live Attenuated Rotavirus Vaccine Price (US$/Dose) by Type (2021–2032)
Figure 54. Global Sales Market Share of Live Attenuated Rotavirus Vaccine by Application (2021–2032)
Figure 55. Global Revenue Market Share of Live Attenuated Rotavirus Vaccine by Application (2021–2032)
Figure 56. Global Live Attenuated Rotavirus Vaccine Price (US$/Dose) by Application (2021–2032)
Figure 57. Live Attenuated Rotavirus Vaccine Value Chain
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
